Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
As of close of business last night, TherapeuticsMD Inc’s stock clocked out at $1.00, down -23.08% from its previous closing price of $1.30. In other words, the price has decreased by -$23.08 from its previous closing price. On the day, 0.64 million shares were traded.
Ratios:
To gain a deeper understanding of TXMD’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.64 and its Current Ratio is at 1.64. In the meantime, Its Debt-to-Equity ratio is 0.27 whereas as Long-Term Debt/Eq ratio is at 0.21.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 22 ’24 when Collins Cooper C. bought 4,094 shares for $1.73 per share. The transaction valued at 7,099 led to the insider holds 52,016 shares of the business.
Collins Cooper C. bought 1,200 shares of TXMD for $2,039 on Aug 21 ’24. The Director now owns 47,922 shares after completing the transaction at $1.70 per share.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 7.21 while its Price-to-Book (P/B) ratio in mrq is 0.43.
Stock Price History:
Over the past 52 weeks, TXMD has reached a high of $2.75, while it has fallen to a 52-week low of $0.70. The 50-Day Moving Average of the stock is -9.22%, while the 200-Day Moving Average is calculated to be -36.46%.
Shares Statistics:
A total of 11.53M shares are outstanding, with a floating share count of 11.34M. Insiders hold about 1.71% of the company’s shares, while institutions hold 30.61% stake in the company.
